These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 19665876)

  • 1. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
    Bishburg E; Bishburg K
    Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus: the superbug.
    Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY; Ng LS; Tan E; Huang G
    J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S; Tribuddharat C; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness.
    Cunha BA
    Int J Antimicrob Agents; 2010 May; 35(5):517-8. PubMed ID: 20202796
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimizing therapy for Acinetobacter baumannii.
    Peleg AY
    Semin Respir Crit Care Med; 2007 Dec; 28(6):662-71. PubMed ID: 18095230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of multiresistant Acinetobacter baumannii infections.
    Pachón J; Vila J
    Curr Opin Investig Drugs; 2009 Feb; 10(2):150-6. PubMed ID: 19197792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.
    Hanlon GW
    Lett Appl Microbiol; 2005; 41(5):375-8. PubMed ID: 16238638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A; D'Arezzo S; Visca P; Petrosillo N;
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic options for Acinetobacter baumannii infections.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
    Huigens RW; Reyes S; Reed CS; Bunders C; Rogers SA; Steinhauer AT; Melander C
    Bioorg Med Chem; 2010 Jan; 18(2):663-74. PubMed ID: 20044260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P; Kim A; Nicolau DP
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii.
    Goff DA; Kaye KS
    Clin Infect Dis; 2014 Dec; 59 Suppl 6():S365-6. PubMed ID: 25371511
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Sun C; Falagas ME; Wang R; Karageorgopoulos DE; Yu X; Liu Y; Cai Y; Liang B; Song X; Liu Z
    J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
    Seifert H; Stefanik D; Wisplinghoff H
    J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
    [No Abstract]   [Full Text] [Related]  

  • 20. Is minocycline a solution for multidrug-resistant Acinetobacter baumannii?
    Neonakis IK; Spandidos DA; Petinaki E
    Future Microbiol; 2014; 9(3):299-305. PubMed ID: 24762305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.